Immix Biopharma (IMMX) Return on Assets [ROA] (2022 - 2026)
Immix Biopharma's Return on Assets [ROA] was -23.84% in Q2 2026, up 106.35 percentage points from -130.19% a year earlier and up 11.03 percentage points from the prior quarter.
Powered by 
Analysis
Immix Biopharma (IMMX) Return on Assets [ROA] (2022 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at Immix Biopharma came in at -46.07%, up 55.15 percentage points from FY2024.
- Return on Assets [ROA] shows a four-year change of +214.27 percentage points (FY2021 to FY2025).
- In earlier years, Return on Assets [ROA] was -101.22% in FY2024 (-11.68 pp), -89.54% in FY2023 (-39.82 pp), -49.73% in FY2022 (+210.62 pp) and -260.35% in FY2021.
- The Q2 2026 figure marks the highest quarterly Return on Assets [ROA] in data going back to Q1 2022.
- Compared with a year earlier, Return on Assets [ROA] has increased for three straight quarters, with an average year-over-year change of +4.93 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q2 2026 (a gain of 106.35 percentage points); the worst was Q2 2025 (a drop of 69.30 percentage points).
- Per Business Quant data, IMMX's Return on Assets [ROA] in the three quarters before Q2 2026 was -34.87% (Q1 2026), -47.13% (Q4 2025) and -131.95% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | Immix Biopharma | 692.47 Mn | 692.47 Mn | - | -23.84% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -23.84% |
| Mar 31, 2026 | -34.87% |
| Dec 31, 2025 | -47.13% |
| Sep 30, 2025 | -131.95% |
| Jun 30, 2025 | -130.19% |
| Mar 31, 2025 | -97.62% |
| Dec 31, 2024 | -90.24% |
| Sep 30, 2024 | -81.67% |
| Jun 30, 2024 | -60.89% |
| Mar 31, 2024 | -67.91% |
| Dec 31, 2023 | -73.56% |
| Sep 30, 2023 | -74.87% |
| Jun 30, 2023 | -79.44% |
| Mar 31, 2023 | -66.83% |
| Dec 31, 2022 | -50.95% |
| Sep 30, 2022 | -149.03% |
| Jun 30, 2022 | -133.25% |
| Mar 31, 2022 | -129.28% |
API Access
Immix Biopharma Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=IMMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "IMMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=IMMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();